New shot could tame birch pollen allergies, early trial hopes
Symptom relief
Completed
This Phase 2 trial tests whether an injection called DM-101PX can reduce nasal symptoms caused by birch pollen allergy. About 100 adults with birch pollen allergic rhinitis or rhinoconjunctivitis will receive either the drug or a placebo. The main goal is to see if the treatment …
Phase 2 • Sponsor: Desentum Oy • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC